课题基金 / 基金详情

Phage treatment and wetland technology as intervention strategy to prevent dissemination of antibiotic resistance in surface waters

Phage treatment and wetland technology as intervention strategy to prevent dissemination of antibiotic resistance in surface waters
噬菌体处理和湿地技术作为防止地表水中抗生素耐药性传播的干预策略
批准号:
MR/W031205/1
负责人:
Evelien Adriaenssens
金额:
$44.39万
依托单位:
依托单位国家:
英国
项目类别:
Research Grant
财政年份:
2022
资助国家:
英国
项目状态:
未结题
起止时间:
2022 至 --

项目摘要

项目成果

Evelien Adriaenssens的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Urban wastewater contains antibiotic residues and human-derived microorganisms, including well-known human disease causing bacteria (pathogens) which are resistant to antibiotics. These may withstand either traditional treatment in waster water treatment plants or passive treatment in constructed wetlands presenting a serious health risk particularly in Low to Middle Income Countries (LMIC). In this proposed research, the Phageland consortium aims to develop a new low-cost, safe, eco-friendly and scalable intervention strategy to prevent the transmission of antibiotic resistance (AR) from wastewater into surface waters. This will be achieved by combining the use of specific bacteria-infecting viruses (bacteriophages also known as phages) to created a phage-based treatment in combination with constructed wetlands acting as passive water treatment systems. The research partners will evaluate this technology with respect to its efficacy in removing key antibiotic resistant pathogens from wastewater, ecological safety, including preservation of natural bacterial diversity, and potential side effects for the wider environment including animals.The PhageLand technology will also be tested in a scaled-up pilot infrastructure as a proof-of-concept for the strategy and its viability for deployment in LMICs where economic constraints limit the construction of more costly and power hungry treatment technologies. The project will use a combination of field and laboratory experiments, including cutting edge techniques and environmental engineering, to address current gaps in knowledge and both assess and develop the PhageLand technology.The initial focus will be on post-Soviet European LMICs, and specifically Moldova as a model country, which have historically been overlooked amongst LMICs as a whole. However, the proposed technology will be universally applicable and easily transferred to other countries regardless of economic status.
期刊论文(5)
专著(0)
科研奖励(0)
会议论文
Decoding Huge Phage Diversity: A Taxonomic Classification of Lak Megaphages
解码巨大的噬菌体多样性:Lak 巨噬细胞的分类学
DOI: 10.1101/2024.02.01.578382
发表时间: 2024
期刊:
影响因子: --
作者: [Cook R]
通讯作者: Cook R
Bacteriophage Taxonomy: A Continually Evolving Discipline.
噬菌体分类学:一门不断发展的学科。
DOI: 10.1007/978-1-0716-3523-0_3
发表时间: 2024
期刊: Methods in molecular biology (Clifton, N.J.)
影响因子: --
作者: [Turner D]
通讯作者: Turner D
DOI: 10.1097/mcp.0000000000001050
发表时间: 2024-05-01
期刊: CURRENT OPINION IN PULMONARY MEDICINE
影响因子: 3.3
作者: [Dominic,Catherine, Pye,Hannah V., Adriaenssens,Evelien M.]
通讯作者: Adriaenssens,Evelien M.
Bacterioph00ages for gut health
  • 批准号:
    BB/W015706/1
  • 项目类别:
    Research Grant
  • 资助金额:
    $78.3万
  • 财政年份:
    2022
  • 负责人:
    Evelien Adriaenssens
  • 依托单位:
Canada Partnering Award: A one health approach to understanding and using bacteriophages in the control of enteric pathogens
  • 批准号:
    BB/V018086/1
  • 项目类别:
    Research Grant
  • 资助金额:
    $4.31万
  • 财政年份:
    2021
  • 负责人:
    Evelien Adriaenssens
  • 依托单位:
国内基金
海外基金
基于MFSD2A调控血迷路屏障跨细胞囊泡转运机制的噪声性听力损失防治研究
  • 批准号:
    82371144
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    汪雪玲
  • 依托单位:
噬菌体靶向肠道粪肠球菌提高帕金森病左旋多巴疗效的机制研究
  • 批准号:
    82371251
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    肖勤
  • 依托单位:
基于密度泛函理论金原子簇放射性药物设计、制备及其在肺癌诊疗中的应用研究
  • 批准号:
    82371997
  • 项目类别:
    面上项目
  • 资助金额:
    48.00万元
  • 批准年份:
    2023
  • 负责人:
    张春富
  • 依托单位:
靶向PARylation介导的DNA损伤修复途径在恶性肿瘤治疗中的作用与分子机制研究